Merit Financial Group
GOSS icon

Merit Financial Group’s Gossamer Bio GOSS Stock Holding History

Merit Financial Group’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.9K Buy
2,120
+189
+10% +$4.22K ﹤0.01% 2323
2026
Q1 		$50.7K Sell
1,931
-9
-0.5% -$1.13K ﹤0.01% 2059
2025
Q4 		$481K Buy
1,940
+256
+15% +$58.4K ﹤0.01% 1329
2025
Q3 		$354K Buy
+1,684
New +$297K ﹤0.01% 1345

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DeepCurrents Investment Group
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
Context Capital Management
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
Worth Venture Partners
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GSA Capital Partners
GSA Capital Partners London, United Kingdom $1.59B AUM 39.8% 1-Year Est. Return
Wolverine Asset Management
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Merit Financial Group's GOSS Position: Q2 2026 in Review

Merit Financial Group increased its Gossamer Bio (GOSS) stake by 9.8% in Q2 2026, buying an estimated $4.22K and bringing the position to 2,120 shares worth $27.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2323.

Merit Financial Group first reported a position in GOSS in Q3 2025 and has held it in 4 quarters since. The position peaked at $481K in Q4 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Merit Financial Group held 2,120 shares of Gossamer Bio worth $27.9K as of Q2 2026.
  • Merit Financial Group bought 189 Gossamer Bio shares in Q2 2026, an estimated $4.22K.
  • Gossamer Bio made up ﹤0.01% of Merit Financial Group's portfolio in Q2 2026, its #2323 holding.
  • Merit Financial Group first reported a position in Gossamer Bio in Q3 2025 and has held it in 4 quarters since.
  • Merit Financial Group's Gossamer Bio position peaked at $481K in Q4 2025.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.